Carrying Out of Focus Group to Improve Cervical Screening Proposal by Vaginal Self-sampling (APACHE-4/FG).
Carrying Out of Focus Group to Improve Cervical Screening Proposal by Vaginal Self-sampling (APACHE-4/FG).
Despite the existence of an effective screening test (pap smear), cervical cancer is, every
 year in France, the cause of more than 3,000 new cases and 1,100 deaths. But, in France, 4 in
 10 women are not screened or not often enough (nearly 7 millions women). It is therefore
 necessary to develop new strategies to reach these women. The etiological factor of this
 cancer is persistent infection with oncogenic High-Risk Human PapillomaVirus (HR-HPV).
 Thereby, HPV-based tests could be alternative screening tests. Vaginal self-sampling with
 HR-HPV test is simpler and less intrusive than the pap smear. It has been shown that vaginal
 self-sampling with HPV test is a powerful means to increase the participation rate in
 cervical cancer screening. The investigators hypothesize that it is possible to optimize
 participation rate by improving the communication media associated to the vaginal
 self-sampling kit. This is why the accompanying letter and the leaflet explaining how to
 perform the vaginal self-sampling will be submit to women opinion by using the Focus Group
 method. The objective is to identify improvement ideas of these two communication media.
Inclusion Criteria:

 -  women from 30 to 65 years old

 -  women living in french territorial division 37 ("Indre-et-Loire")

 -  no pap smear made in the three last years (ideally)

 Exclusion Criteria:

 -  Follow-up in progress for positive screening